Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
M Rotta, K Anderson - Leukemia, 2005 - nature.com
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
[引用][C] Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
B BRUNO, L GIACCONE, M ROTTA… - …, 2005 - pascal-francis.inist.fr
Novel targeted drugs for the treatment of multiple myeloma : from bench to bedside CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
B Bruno, L Giaccone, M Rotta, K Anderson… - …, 2005 - pubmed.ncbi.nlm.nih.gov
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
B Bruno, L Giaccone, M Rotta, K Anderson… - Leukemia, 2005 - go.gale.com
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
[PDF][PDF] Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
M Center - Leukemia, 2005 - researchgate.net
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside.
B Bruno, L Giaccone, M Rotta… - Leukemia …, 2005 - search.ebscohost.com
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside.
B Bruno, L Giaccone, M Rotta, K Anderson… - Leukemia, 2005 - europepmc.org
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
[PDF][PDF] Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
M Center - Leukemia, 2005 - academia.edu
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …
Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside
B Bruno, L Giaccone, M Rotta, K Anderson… - LEUKEMIA, 2005 - iris.unito.it
Multiple myeloma remains an incurable plasma cell neoplasm. New insights into its
pathogenesis have identified signaling pathways that have become potential therapeutic …
pathogenesis have identified signaling pathways that have become potential therapeutic …